IGHG3 and infection: Similarly, HVTN 705 (Imbokodo), testing mosaic Ad26 and gp140 vaccines, presented no efficacy and low V1V2-specific antibody responses, though higher V1V2 IgG3 breadth scores trended toward decreased infection risk across multiple statistic models (12).